A Phase I/II Study of HE3235 in Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00716794
Recruitment Status : Completed
First Posted : July 16, 2008
Last Update Posted : March 9, 2011
Information provided by:
Harbor Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : March 2011